Γ—

Tag: Alzheimer's

Astrocyte
An article in GeroScience describes a previously unexplored relationship between FABP7, an inflammatory molecule that binds to fatty acids, and Alzheimer's disease. Not just a transporter Originally, as the authors explain, fatty acid binding proteins (FABPs) were considered to be simple biological chaperones that did not perform biological functions. Further research found that they play...
Amyloid beta plaques
In a study published in Cell Stem Cell, researchers have investigated a way to repopulate the brain with functional cells in order to fight back against Alzheimer's disease. A gene with a microglial function Various allelles of the apolipoprotein E (APOE) genes are well-known for their contributions to, or defenses against, Alzheimer's, as they affect...
Herpes simplex
  One of the most common diseases in the world is herpes, as 50 to 80% of Americans have this illness. The herpes simplex virus, which causes cold sores, is normally transmitted through person-to-person contact. This illness leaves the patient with blisters clustered around the mouth. Gradually, the blisters pop and leave sores that take...
Vaccination
New research suggests that vaccination against shingles, a disease caused by the varicella zoster virus, can provide some protection against Alzheimer’s disease, mostly in women [1]. Viruses and aging With causes of many age-related diseases remaining unclear, in recent years, scientists have been looking into the possible influence of bacteria and viruses. One new paper...
Genetic mutation
Scientists studying people with autosomal dominant Alzheimer’s disease have found a genetic variant that is associated with decades of stalled onset [1]. The predictable Alzheimer’s Scientists still do not know what causes most cases of Alzheimer's, although certain genetic variants (most notably APOE4) have been shown to increase the risk of onset [2]. However, there...
Alzheimer's biomarker
Researchers publishing in Alzheimer's and Dementia have published a correlation between the Alzheimer's-linked protein tau and another protein, bisecting N-acetylglucosamine (GlcNAc), which suggests its usefulness as a biomarker. The need for early prediction This paper begins with a note that to be effective, Alzheimer's treatment must begin before irrevocable neurodegeneration has already occurred [1]. Therefore,...